NASDAQ: EPRX
Eupraxia Pharmaceuticals Inc Stock Ownership - Who owns Eupraxia Pharmaceuticals?

Insider buying vs selling

Have Eupraxia Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EPRX insiders and whales buy or sell their stock.

EPRX Shareholders

What type of owners hold Eupraxia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Beugoo0.01%3,628$29.06kInstitution
Beutel Goodman Co Ltd0.01%3,627$29.05kInstitution
Affini0.00%1,650$13.22kInstitution
Affinity Asset Advisors LLC0.00%1,650$13.22kInstitution
Vivoca0.00%1,350$10.81kInstitution
Balyas0.00%1,350$10.81kInstitution
Balyasny Asset Management LP0.00%1,350$10.81kInstitution
Vivo Capital LLC0.00%1,350$10.81kInstitution
Scotia0.00%1,344$10.77kInstitution
Scotia Capital Inc0.00%1,343$10.76kInstitution

1 of 3

EPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EPRX0.04%0.00%
PRME0.06%63.21%
SLN0.02%0.09%
CBIO0.04%99.96%Net BuyingNet Buying
INDP0.00%74.86%Net Buying

Eupraxia Pharmaceuticals Stock Ownership FAQ

Who owns Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals (NASDAQ: EPRX) is owned by 0.04% institutional shareholders, 0.00% Eupraxia Pharmaceuticals insiders, and 99.96% retail investors. Beugoo is the largest individual Eupraxia Pharmaceuticals shareholder, owning 3628.00 shares representing 0.01% of the company. Beugoo's Eupraxia Pharmaceuticals shares are currently valued at $29.06k.

If you're new to stock investing, here's how to buy Eupraxia Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.